Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 407
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01450137 | Tocilizumab for Patients With Giant Cell Arteritis | ||
| NCT07365930 | NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy | ||
| NCT02407080 | Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia | ||
| NCT03272477 | Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients | ||
| NCT00484328 | Ribavirin, Its Dosing Regime | ||
| NCT00144976 | Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma | ||
| NCT03229382 | Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse | ||
| NCT03341520 | Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma | ||
| NCT05007613 | Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma | ||
| NCT00411762 | A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma | ||
| NCT01596790 | COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer | ||
| NCT03519295 | A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma | ||
| NCT01423695 | Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer | ||
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | ||
| NCT00938444 | Evaluation of the BRADA and ABILHAND Questionnaires | ||
| NCT00738829 | Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL | ||
| NCT02575157 | Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates | ||
| NCT01565200 | HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1 | ||
| NCT04708639 | Monitoring Alectinib Treatment by Detection of ALK Translocations in Serial Blood Samples From Non-Small Cell Lung Cancer Patients | ||
| NCT00198146 | Prevention of Diabetes Progression Trial (PDPT) | ||
| NCT00485589 | A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM) | ||
| NCT04896710 | COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample | ||
| NCT04759248 | Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer | ||
| NCT01195298 | Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer | ||
| NCT01661790 | Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer | ||
| NCT01713218 | Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer | ||
| NCT05293015 | NP-Supported Multidisciplinary Diabetes Management During Perioperative Period | ||
| NCT04292574 | UK SMA Patient Registry | ||
| NCT02433522 | Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab | ||
| NCT04335071 | Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) | ||
| NCT00112931 | Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma | ||
| NCT00079053 | Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
| NCT04490044 | Under and Over Rehabilitation Study | ||
| NCT03324633 | Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV | ||
| NCT02003703 | Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . | ||
| NCT01259817 | Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) | ||
| NCT01457144 | Study of Mantle Cell Lymphoma Treatment by RiBVD | ||
| NCT05966233 | R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma | ||
| NCT02099292 | Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma | ||
| NCT05038657 | Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). | ||
| NCT01817452 | A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol | ||
| NCT00910676 | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors | ||
| NCT05919342 | Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF" | ||
| NCT00730769 | Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients | ||
| NCT04253561 | Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients | ||
| NCT01709097 | Compliance/Adherence After Kidney Transplant, With or With Out Med-O-Wheel™. | ||
| NCT03147040 | AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer | ||
| NCT04497285 | Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer | ||
| NCT00676715 | A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis | ||
| NCT01015352 | Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA) |
